minocycline and Communicable-Diseases--Emerging

minocycline has been researched along with Communicable-Diseases--Emerging* in 4 studies

Reviews

2 review(s) available for minocycline and Communicable-Diseases--Emerging

ArticleYear
Emerging pathogen: a case and review of Raoultella planticola.
    Infection, 2014, Volume: 42, Issue:6

    Raoultella planticola has been considered a relatively harmless Gram-negative bacteria, rarely associated with clinical infection. However, in recent years, the frequency at which severe infection by R. planticola and drug-resistant strains are reported in literature has increased. Here, we present one case of acute cholecystitis caused by R. planticola, and review all previously reported cases of the infection in an attempt to identify new trends in biological and clinical features of R. planticola infections.

    Topics: Abdominal Pain; Aged; Aged, 80 and over; Alcoholism; Anti-Bacterial Agents; Cholecystitis, Acute; Communicable Diseases, Emerging; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Minocycline; Tigecycline

2014
Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.
    Critical care nurse, 2008, Volume: 28, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Arizona; Centers for Disease Control and Prevention, U.S.; Colistin; Communicable Diseases, Emerging; Critical Care; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Equipment Contamination; Genes, Bacterial; Genes, MDR; Humans; Infection Control; Minocycline; Nursing Staff, Hospital; Risk Factors; Tigecycline; Total Quality Management; United States

2008

Other Studies

2 other study(ies) available for minocycline and Communicable-Diseases--Emerging

ArticleYear
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:7

    Acinetobacter baumannii is one of the antibiotic-resistant superbugs that threatens hospitalized patients. Emergence and spread of the multidrug-resistant (MDR) and extensively drug-resistant (XDR) clones cause erratic outbreaks following environmental contamination of hospital settings.. The present study intended to characterize the antimicrobial resistant profiles and the genotypes of clinical and environmental isolates of A. baumannii as a result of dissemination of resistant strains.. Clinical and environmental isolates of A. baumannii were obtained from patients, staff, and environment of an educational hospital in Tehran. Antimicrobial susceptibility testing was carried out using the disk diffusion and E-test methods. Multiplex PCR was performed for detection of OXA-type genes (bla. All the isolates were found to be susceptible to colistin and most of them (77%) were non-susceptible to tigecycline. A majority of the clinical and environmental isolates (97%) were considered as MDR strains and 41% as XDR. In multiplex detection, bla. The present study highlights the circulation of drug-resistant A. baumannii strains in different wards of hospitals principally in intensive care unit (ICU) as a nosocomial pathogen due to unwise managements.

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline

2018
The first reported case of spotted fever in Fukui Prefecture, the northern part of central Japan.
    Japanese journal of infectious diseases, 2005, Volume: 58, Issue:2

    A 53-year-old man visited Mt. Arashima-dake in Fukui Prefecture, and was infested by a tick-like organism. He visited a local clinic on July 12, 2004, complaining of high fever, general fatigue and rash. After several days without definite diagnosis, he was admitted to the Fukui Prefectural Hospital, where he was treated with minocycline hydrochloride for 10 days until recovery. His clinical symptoms on admission were high fever (39.6 degrees C), erythematous eruption, eschar on the right upper arm, and regional lymphoadenopathy. The epidemiological status and some clinical findings strongly suggested spotted fever (SF), and SF was confirmed based on the finding that his sera were reactive only to antigens of the SF group rickettsiae in the indirect immunoperoxidase analysis. This case is the first official report of SF rickettsiosis in Fukui Prefecture, the northern part of central Japan.

    Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Humans; Japan; Male; Middle Aged; Minocycline; Rickettsia Infections; Tick-Borne Diseases

2005